Emerging preclinical findings support the feasibility of nanoparticle-mediated CRISPR/Cas9 delivery, although direct evidence in infant neuroblastoma remains limited and the evidence for nanoparticle-mediated CRISPR/Cas9 therapy remains largely preclinical.
Samruddhi Kaknale, Ayush Ranjan, I. V. Enoch et al.· Molecular Biology Reports· 0 citations
In this work, SnO2–CuO composites were synthesized in a 1:1 ratio using the co-precipitation method and calcined at varying temperatures from 300 to 600 °C. X-ray diffraction (XRD) confirmed a phase transition from semicrystalline to crystalline with increasing temperature, accompanied by crystallite growth from 8 nm t...
J. Johns, V. H. Sree, J. Selvin et al.· Journal of materials science...· 0 citations
This comprehensive review on Nanotechnology focuses on the entire spectrum of ovarian cancer management and recent advances in physicochemical properties, PK/BD, diagnostic biosensors, treatment modalities to reverse MDR, immunomodulation and personalized nanomedicine are summarized.
Sudhaker Raboni Grace, Mano Magdalin Rubella Kennedy, I. V. Enoch· BioNanoScience· 0 citations
An up-to-date summary of the use of nanomaterials in lung cancer therapy is provided by categorising various types of nanocarriers, discussing their mechanisms for circumventing physiological barriers and emphasizing their role in the development of next-generation therapies, especially immunotherapy and molecular diag...
Ramaraj Rajesh Kumar, I. V. Enoch· Lung Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.